Bolt Biotherapeutics (BOLT) Asset Utilization Ratio (2021 - 2026)
Bolt Biotherapeutics (BOLT) posted Asset Utilization Ratio of 0.12 for Q1 2026, down 1.82% sequentially from 0.13 in Q4 2025, and up 216.27% YoY from 0.04 in Q1 2025.
Bolt Biotherapeutics (BOLT) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Bolt Biotherapeutics has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.12 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 216.27% year-over-year to 0.12 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.12 (up 216.27% YoY) and the FY2025 annual result came in at 0.1, up 66.0% from the prior year.
- Asset Utilization Ratio eased to 0.12 in Q1 2026 per BOLT's latest filing, from 0.13 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.13 in Q4 2025 and troughed at 0.01 in Q1 2022.
- A 5-year average of 0.06 and a median of 0.05 in 2023 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio surged 6299.0% in 2022, then sank 47.58% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.02 in 2022, then surged by 94.16% to 0.05 in 2023, then surged by 56.59% to 0.07 in 2024, then jumped by 71.68% to 0.13 in 2025, then dropped by 1.82% to 0.12 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.12, 0.13, and 0.07 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Bolt Biotherapeutics | 6.10 Mn | 6.10 Mn | - | 0.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.11 |
| Mar 31, 2026 | 0.12 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | 0.07 |
| Jun 30, 2025 | 0.05 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | 0.07 |
| Sep 30, 2024 | 0.08 |
| Jun 30, 2024 | 0.08 |
| Mar 31, 2024 | 0.07 |
| Dec 31, 2023 | 0.05 |
| Sep 30, 2023 | 0.04 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |